Research and Markets (http://www.researchandmarkets.com/research/t39s36/adrenocortical) has announced the addition of the "Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Adrenocortical Carcinoma Adrenal Cortex Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Adrenocortical Carcinoma Adrenal Cortex Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Adrenocortical Carcinoma Adrenal Cortex Cancer Overview
  3. Therapeutics Development
  4. Pipeline Products for Adrenocortical Carcinoma Adrenal Cortex Cancer - Overview
  5. Pipeline Products for Adrenocortical Carcinoma Adrenal Cortex Cancer - Comparative Analysis
  6. Adrenocortical Carcinoma Adrenal Cortex Cancer - Therapeutics under Development by Companies
  7. Adrenocortical Carcinoma Adrenal Cortex Cancer - Therapeutics under Investigation by Universities/Institutes
  8. Adrenocortical Carcinoma Adrenal Cortex Cancer - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Adrenocortical Carcinoma Adrenal Cortex Cancer - Products under Development by Companies
  13. Adrenocortical Carcinoma Adrenal Cortex Cancer - Products under Investigation by Universities/Institutes
  14. Adrenocortical Carcinoma Adrenal Cortex Cancer - Companies Involved in Therapeutics Development
  • Arbutus Biopharma Corporation
  • ArQule, Inc.
  • EnGeneIC Ltd
  • Marathon Pharmaceuticals, LLC
  • Merck KGaA
  • Orphagen Pharmaceuticals, Inc.

For more information visit http://www.researchandmarkets.com/research/t39s36/adrenocortical